NeoVirTech’s mission is to provide researcher state of the art virology assays using innovative, image based readout. Virology testing requires expertise, know-how and reglementary facilities involving laboratory confinement that can be difficult to access in classical labs. Also, classical virology methods are expensive and time consuming and slow down discovery processes.  

At NeoVirTech we have developed an ever-expanding catalogue of autofluorescent viruses and viral vectors for the direct imaging of antiviral drug candidates effect or disinfection procedure in the field of human health, animal health and biodefense.

The company exploits and provides access to its proprietary ANCHOR™ technology to both academic and industrial customers and has the ability to convert any kind of DNA into an autofluorescent particle. ANCHOR™ allows fast, stable, precise and quantitative measurement of virus replication in living cells, providing our customer with the best virology testing method available. The asset of ANCHOR™ technology : no fixation, no extraction, no reagents, no staining, direct imaging of viral infection and replication.

Driven by innovation, we have expended our activities on a broad variety of field, including antiviral discovery, vaccine development, oncolytic therapies, gene therapy and decontamination testing using infectious viruses.

Among our CRO activities, we have also developed proprietary product displaying broad spectrum antiviral activities that we are positioning on emerging market.

Our goal is to speed up discovery process of any solution having an impact in the infectious disease field.